James Huang, Director at CASI Pharmaceuticals, holds 13.16M shares in Connect Biopharma Holdings (Ticker: CNTB), holds 3.75M shares in Windtree Therapeutics (Ticker: WINT), holds 371.71K shares in CASI Pharmaceuticals (Ticker: CASIF). Most recently, James Huang Bought ― shares of Connect Biopharma Holdings on Apr 01, 2026 for an estimated value of $4.00M.
What is the percentage of profitable transactions made by James Huang?
The percentage of profitable transactions made by James Huang is 6%.
What is the average return per transaction made by James Huang?
The average return per transaction made by James Huang is -50.30%.
What stocks does James Huang hold?
James Huang holds: CASIF, WINT, TCRT, CNTB stocks.
What was James Huang’s latest transaction?
James Huang latest transaction was an Informative Buy of $4.00M.
What was James Huang's most profitable transaction?
James Huang’s most profitable transaction was an Informative Buy of TCRT stock on September 3, 2021. The return on the trade was 75.70%.
What is James Huang's role in CASI Pharmaceuticals?
James Huang's role in CASI Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.